Table 1. Information of the CML patients and the health volunteers.

Characteristics		HC	UCML	SCML	RCML
Sex	Male	9	17	17	8
	Female	9	9	2	6
Age (year)	Mean±SD	35.2±9.2	37.6±13.4	38.1±15.7	39.2±14.1
	range	18–55	18–67	23–70	18–69
Recent medicine		No	Hydroxycarbamide	Imatinib	Imatinib
Duration of disease	Mean±SD		8.3±12.6	17.8±24.2	48.5±31.6
(months)	range		1–33	6–84	6–168
Duration of imatinib	Mean±SD			12.2±23.3	25.9±12.7
treatment (months)	range			6–72	6–39
Daily dose (mg)	Mean±SD			418±52	421±77
	range			400–600	300–800